44K-27838-97071
4 vaccinations
3 coded responses
44 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 631 / MO
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Registered in v-safe
-
2020-12-24
Dose 1 — Pfizer-BioNTech
- 2020-12-24
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-07
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-28
- 2021-02-04
-
2021-02-11
Survey response — day 28, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: I experienced a couple of episodes of Reynauds (fingers only) in my early 40s (~15 years ago). No other episodes until I received my second Covid vaccine (1/14/2021), after which I have had several episodes of Reynauds, none of which were serioMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-25
-
2021-04-15
Survey response — 3 months, dose 2MedDRA: Pre-existing disease, Raynaud's phenomenon — Feeling: GoodFree text: The episodes of Reynauds phenomenon (that occurred occasionally for 1 to 2 weeks after my second vaccination) resolved completely, and I have been asymptomatic since that time.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-15
-
2021-09-23
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-09-30
- 2021-10-16
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-12-24
- 2022-03-24
-
2022-03-31
Dose 4 — Pfizer-BioNTech
- 2022-03-31
-
2022-04-01
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-02
- 2022-04-03
- 2022-04-04
- 2022-04-05
- 2022-04-06
- 2022-04-07
- 2022-04-14
- 2022-04-21
- 2022-04-28
- 2022-05-05
-
2022-05-12
Survey response — day 42, dose 4MedDRA: Cough, Laryngitis, Pyrexia — Feeling: GoodFree text: Laryngitis, cough, and fever; resolved after a few days.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-30
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-09-23 | Pfizer-BioNTech | No |
| 4 | 2022-03-31 | Pfizer-BioNTech | No |
Free text
Release 4 — day 28, dose 2
Symptoms: I experienced a couple of episodes of Reynauds (fingers only) in my early 40s (~15 years ago). No other episodes until I received my second Covid vaccine (1/14/2021), after which I have had several episodes of Reynauds, none of which were serio
Release 7 — 3 months, dose 2
Symptoms: The episodes of Reynauds phenomenon (that occurred occasionally for 1 to 2 weeks after my second vaccination) resolved completely, and I have been asymptomatic since that time.
Release 11 — day 42, dose 4
Symptoms: Laryngitis, cough, and fever; resolved after a few days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Raynaud's phenomenon | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release